This isnâ€™t about genetic genealogy or even genealogy, but itâ€™s too interesting to pass up.
A recent Fortune article titled â€œHow Facebook is taking over our livesâ€ points out that roughly 175 million people are members of Facebook, and that the total daily use of Facebook is over 3 billion minutes.
Here are some rough calculations using that 3 billion minutes per day value (and feel free to check my math, please!):Â three billion minutes equals 50 million hours, which equals 2.08 million days, which equals 5,707 years.
Thus, every single day humanity spends the equivalent of over 5,000 years on Facebook!
Among other things, the article mentions several of the projects that focus on African American genetic genealogy, including African Ancestry:
The curiosity has fueled the growth of DNA testing outfits. African Ancestry Inc., a Washington-based firm, has tested the DNA of 15,000 people against its database of 25,000 African genetic lineages, according to its president, Gina M. Paige. The firm’s clients include Winfrey, film director Spike Lee, musician Quincy Jones, comedian Whoopi Goldberg and actors Morgan Freeman and Don Cheadle.
Peter Dizikes at Salon.com writes “Your DNA is a Snitch,” about privacy concerns surrounding genetic testing. Peter contacted me a little while ago and we talked about some of my thoughts on the topic. My opinion on the security measures at genetic testing companies was included in the story:
Early-adopting customers tend to agree [that genetic testing companies can protect personal information]. “They have every incentive to keep information private,” says Blaine Bettinger, a law student and genetics blogger in New York state and a 23andMe customer.” A security breach would be devastating for those companies.” Certainly well-funded firms like Navigenics and 23andMe can devote substantial resources to data protection.
Iâ€™ve been working on a presentation regarding the future of genetic genealogy, and one aspect of that future is the ability to trace DNA (SNPs, mutations, haplogroups, etcâ€¦) through recent history as the result of combining extensive genomic sequencing with massive family tree information.Â Although the ability to do this will have many uses (both for genealogy and for personalized medicine), it will also raise a number of privacy issues, as a recent paper suggests.
In November 2007 I estimated that as of that date 600,000 to 700,000 DNA testing kits had been sold by genetic genealogy companies and that the number was increasing by 80,000 to 100,000 kits per yearÂ (see â€œHow Big is the Genetic Genealogy Market?â€).Â I ended that article with a prediction:Â â€œAs the interest in genetic genealogy grows, I predict that the 1 millionth genetic genealogy customer will push the â€˜buyâ€™ button as early as 2009.â€
It seems my prediction might not have been too far off.Â This week, Family Tree DNA issued a press release stating that the company had recently received an order for the 500,000th testing kit.
FTDNA’s Press Release:
HOUSTON, February 9, 2009 (For Immediate Release) – Family Tree DNA (http://www.familytreedna.com), the world leader in genetic genealogy, announced today that it received its 500,000th DNA test order for genealogy and anthropology purposes.
23andMe and mondoBIOTECH announced at Davos (the World Economic Forum in Switzerland) today that they will work together to further the study of rare diseases.Â According to the press release (below), mondoBIOTECH will identify individuals suffering from certain rare diseases and sponsor their enrollment in the 23andMe Personal Genome Serviceâ„¢.Â Researchers will use the information collected to learn more about the potential causes of these rare diseases.
Linda Avey appeared on CNBC this morning to discuss the company and the partnership â€“ see â€œIt’s All in the Genes.â€
The Press Release:
Davos, Switzerland â€“ January 28th 2009 â€“ 23andMe, Inc., an industry leader in personal genetics, and Mondobiotech AG, a Swiss research company dedicated to the development of treatments for rare diseases, today announced at the World Economic Forum in Davos, Switzerland, that they are collaborating to advance research of rare diseases.
Additionally, Colleen was featured in “Does Publishing Need Genealogists?” by Publisher’s Weekly for her work in researching the circumstances surrounding two recent publishing cases: Misha Defonseca’s Misha: A Memoire of the Holocaust and Herman Rosenblat’s Angel at the Fence. From the article:
Their research uncovered baptismal and school records proving that Defonseca didn’t escape the Holocaust by running with wolves. She didn’t need to; her father was a Nazi collaborator. And if Defonseca had denied the evidence, Fitzpatrick and Sergeant were prepared to use DNA, which, along with photographs and archival records, are a forensic genealogist’s stock in trade. â€œI almost feel disappointed that Misha confessed,â€ wrote Fitzpatrick on her IdentiFinders.com Web site. â€œI was looking forward to identifying her through DNA.â€
I’ve long been interested in the success and long-term outlook of the genealogy market.Â Although altruistic genealogists have done immense amounts of work to transcribe and put records online, one of the strongest forces behind the digitization of genealogical records has been private profit-driven organizations.Â And these organizations, of course, rely on the viability of the market.
FTM Media Kit
Randy Seaver at Genea-Musings recently linked to Family Tree Magazine’s 46 page 2009 Media Kit, which contains extensive information about the genealogy market and the Family Tree Magazine audience.Â The report is filled with statistics about all facets of genealogy and genealogists, and the author(s) include links to all their primary information.
This is an interesting development and suggests that innovative developments in genealogy are continuing and that they can be profitable (for instance, see Geni.comâ€™s latest round of VC).Â In the past few months, FamilyLink.com, Inc. has hired a new a new president (Steve Nickle), vice president (Jim Erickson), and chief technology officer (Allan Carroll).
Although I can hardly hope to introduce or discuss these recent events any better than Daniel MacArthur has alreadygiven at Genetic Future, I will at least bring this new information to your attention.
Last Wednesday the New York Times printed â€œMy Genome, My Selfâ€, an article written by Stephen Pinker, one of the Personal Genome Projectâ€™s â€œFirst 10.â€Â In the article, Pinker talks about his experience with genome sequencing through the PGP.Â It is especially interesting since Pinker analyzes the issue from the point of view of a psychologist.Â I highly recommend reading this article if you are at all interested in personalized medicine or genetics.
Much of the article discusses the confusing results that are returned by genome/disease analysis, due to our current lack of understanding in this enormous field: